Review
doi: 10.1016/s0968-0004(98)01344-9.
Oncogenic alterations of metabolism
Affiliations
- PMID: 10098401
- DOI: 10.1016/s0968-0004(98)01344-9
Item in Clipboard
Review
Oncogenic alterations of metabolism
Trends Biochem Sci.
1999 Feb.
Free article
Abstract
Over seven decades ago, classical biochemical studies showed that tumors have altered metabolic profiles and display high rates of glucose uptake and glycolysis. Although these metabolic changes are not the fundamental defects that cause cancer, they might confer a common advantage on many different types of cancers, which allows the cells to survive and invade. Recent molecular studies have revealed that several of the multiple genetic alterations that cause tumor development directly affect glycolysis, the cellular response to hypoxia and the ability of tumor cells to recruit new blood vessels.
Similar articles
-
Hypoxia and VEGF mRNA expression in human tumors.Neoplasia. 2001 Nov-Dec;3(6):500-8. doi: 10.1038/sj.neo.7900195. Neoplasia. 2001. PMID: 11774032 Free PMC article. Clinical Trial.
-
Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.Cancer Res. 2001 Oct 1;61(19):7349-55. Cancer Res. 2001. PMID: 11585776
-
A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.Jpn J Cancer Res. 2001 Dec;92(12):1342-51. doi: 10.1111/j.1349-7006.2001.tb02159.x. Jpn J Cancer Res. 2001. PMID: 11749701 Free PMC article.
-
The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.Science. 2010 Dec 3;330(6009):1340-4. doi: 10.1126/science.1193494. Science. 2010. PMID: 21127244 Review.
-
Hypoxia-induced regulation of mRNA stability.Adv Exp Med Biol. 2000;475:111-21. doi: 10.1007/0-306-46825-5_11. Adv Exp Med Biol. 2000. PMID: 10849653 Review.
Cited by
-
Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.Free Radic Biol Med. 2015 Jun;83:89-100. doi: 10.1016/j.freeradbiomed.2015.01.031. Epub 2015 Feb 26. Free Radic Biol Med. 2015. PMID: 25725417 Free PMC article.
-
Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus.Medicina (Kaunas). 2023 Nov 16;59(11):2013. doi: 10.3390/medicina59112013. Medicina (Kaunas). 2023. PMID: 38004062 Free PMC article. Review.
-
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.Front Cell Dev Biol. 2021 Mar 1;9:641469. doi: 10.3389/fcell.2021.641469. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33732706 Free PMC article. Review.
-
In vivo genetic dissection of tumor growth and the Warburg effect.Elife. 2016 Sep 1;5:e18126. doi: 10.7554/eLife.18126. Elife. 2016. PMID: 27585295 Free PMC article.
-
Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer.Cancer Sci. 2010 Jun;101(6):1557-61. doi: 10.1111/j.1349-7006.2010.01553.x. Epub 2010 Mar 4. Cancer Sci. 2010. PMID: 20398057 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
